CN104203260A - 用于治疗和预防癌症的包含蒲公英植物根部提取物的药物及其制备方法 - Google Patents

用于治疗和预防癌症的包含蒲公英植物根部提取物的药物及其制备方法 Download PDF

Info

Publication number
CN104203260A
CN104203260A CN201380007584.9A CN201380007584A CN104203260A CN 104203260 A CN104203260 A CN 104203260A CN 201380007584 A CN201380007584 A CN 201380007584A CN 104203260 A CN104203260 A CN 104203260A
Authority
CN
China
Prior art keywords
root
plant
roots
extract
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201380007584.9A
Other languages
English (en)
Chinese (zh)
Inventor
希亚朗·潘迪
卡罗琳·玛丽·哈姆
帕梅拉·乌祖阿左·欧瓦杰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Windsor
Original Assignee
University of Windsor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Windsor filed Critical University of Windsor
Publication of CN104203260A publication Critical patent/CN104203260A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/288—Taraxacum (dandelion)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10—Preparation or pretreatment of starting material
    • A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN201380007584.9A 2012-02-10 2013-02-08 用于治疗和预防癌症的包含蒲公英植物根部提取物的药物及其制备方法 Pending CN104203260A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261597453P 2012-02-10 2012-02-10
US61/597,453 2012-02-10
PCT/CA2013/000114 WO2013116936A1 (en) 2012-02-10 2013-02-08 Medicament containing taraxacum plant root extract for treatment or prevention of cancer, and method for preparing same

Publications (1)

Publication Number Publication Date
CN104203260A true CN104203260A (zh) 2014-12-10

Family

ID=48946859

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201380007584.9A Pending CN104203260A (zh) 2012-02-10 2013-02-08 用于治疗和预防癌症的包含蒲公英植物根部提取物的药物及其制备方法

Country Status (8)

Country Link
US (2) US10179156B2 (https=)
EP (1) EP2817017A4 (https=)
JP (1) JP2015506962A (https=)
CN (1) CN104203260A (https=)
CA (1) CA2863838C (https=)
HK (1) HK1205452A1 (https=)
IN (1) IN2014KN01586A (https=)
WO (1) WO2013116936A1 (https=)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105456444A (zh) * 2015-12-03 2016-04-06 刘彩虹 一种治疗黑色素瘤的中药制剂及其制备方法及应用
CN107996931A (zh) * 2017-12-15 2018-05-08 绥化学院 一种抗菌、强心护肝富氢低糖保健饮料及其制备方法
CN110973632A (zh) * 2019-12-25 2020-04-10 康波 一种进行癌症膳食干预的膳食组合物及其制备方法
CN111603499A (zh) * 2020-05-22 2020-09-01 甘肃岷海医药科技有限公司 一种预防和治疗癌症的中药药物及制备方法
CN113520945A (zh) * 2021-07-30 2021-10-22 云南白药集团上海科技有限公司 蒲公英根提取物、含其皮肤外用剂及其制备方法和应用
CN115089576A (zh) * 2022-07-28 2022-09-23 中国药科大学 木犀草素和菊苣酸联合在制备乳腺癌治疗药物中的应用

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11546275B2 (en) 2020-09-23 2023-01-03 Cisco Technology, Inc. Near-hitless upgrade or fast bootup with mobile virtualized hardware

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11246429A (ja) * 1998-03-02 1999-09-14 Momoya Co Ltd 薬用植物由来の抗腫瘍性物質
HRP990080B1 (en) * 1999-03-12 2003-04-30 Vladimir Leko Plant mixture and a medical preparation for the treatment of diabetes mellitus, type ii, obtained therefrom
JP4521340B2 (ja) * 2005-09-21 2010-08-11 美幸 後藤 コーヒー様飲用組成物、及びコーヒー様飲用組成物の製造方法

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
OVADJE,P: "Selective induction of apoptosis through activation of caspase-8 in human leukemia cells(Jurkat) by dandelion root extract", 《J ETHNOPHARMACOL 》 *
S. J. CHATTERJEE: "The Efficacy of Dandelion Root Extract in Inducing Apoptosis in Drug-Resistant Human Melanoma Cells", 《HTTPS://WWW.NCBI.NLM.NIH.GOV/PMC/ARTICLES/PMC3018636/》 *
李秀珍: "药食兼用的蒲公英", 《微量元素与健康研究》 *
项瑞: "超微粉碎过程温度对羌活有效成分影响的考察", 《2009全国中药创新与研究论坛论文集》 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105456444A (zh) * 2015-12-03 2016-04-06 刘彩虹 一种治疗黑色素瘤的中药制剂及其制备方法及应用
CN107996931A (zh) * 2017-12-15 2018-05-08 绥化学院 一种抗菌、强心护肝富氢低糖保健饮料及其制备方法
CN110973632A (zh) * 2019-12-25 2020-04-10 康波 一种进行癌症膳食干预的膳食组合物及其制备方法
CN111603499A (zh) * 2020-05-22 2020-09-01 甘肃岷海医药科技有限公司 一种预防和治疗癌症的中药药物及制备方法
CN113520945A (zh) * 2021-07-30 2021-10-22 云南白药集团上海科技有限公司 蒲公英根提取物、含其皮肤外用剂及其制备方法和应用
CN115089576A (zh) * 2022-07-28 2022-09-23 中国药科大学 木犀草素和菊苣酸联合在制备乳腺癌治疗药物中的应用
CN115089576B (zh) * 2022-07-28 2023-09-08 中国药科大学 木犀草素和菊苣酸联合在制备乳腺癌治疗药物中的应用

Also Published As

Publication number Publication date
WO2013116936A1 (en) 2013-08-15
US20190105362A1 (en) 2019-04-11
HK1205452A1 (en) 2015-12-18
CA2863838C (en) 2021-03-23
US10179156B2 (en) 2019-01-15
JP2015506962A (ja) 2015-03-05
EP2817017A4 (en) 2015-08-19
IN2014KN01586A (https=) 2015-10-23
EP2817017A1 (en) 2014-12-31
US20150010665A1 (en) 2015-01-08
CA2863838A1 (en) 2013-08-15

Similar Documents

Publication Publication Date Title
US20190105362A1 (en) Medicament Containing Taraxacum Plant Root Extract for Treatment or Prevention of Cancer, and Method for Preparing Same
CN104958440A (zh) 金花茶花提取物及其制备方法和应用
Sharma et al. Ananas comosus (Pineapple): A Comprehensive Review of Its Medicinal Properties, Phytochemical Composition, and Pharmacological Activities.
Rezai et al. Cytotoxic activity of citrullus colocynthis (L.) schrad fruit extract on gastric adenocarcinoma and breast cancer cell lines
Thorat Review on Celosia argentea L. plant
Mardina et al. Preliminary phytochemical screening of different solvent extracts of flower and whole plant of Wedelia biflora
Khan et al. Antilithiatic effect of Helianthus annuus Linn. Leaf extract in ethylene glycol and ammonium chloride induced nephrolithiasis
KR0160108B1 (ko) 조각자나무로부터 추출한 생약 성분으로 된 항암제
Chandran et al. Evaluation of in vivo anticancer activity of Scaevola taccada Roxb against Ehrlich ascites carcinoma in Swiss albino mice
US20160143979A1 (en) Long Pepper Extract an Effective Anticancer Treatment
KR101829810B1 (ko) 청보리잎과 한약재 추출물을 포함하는 발효 조성물 및 이의 제조 방법
ES2906476B2 (es) Extracto etanólico de semillas de Citrullus colocynthis, método para obtenerlo, composición farmacéutica que lo contiene y su uso como agente antitumoral
WO2014183551A1 (zh) 白子菜在制备治疗肝炎的药物或保健食品中的应用
Lokesh et al. Pharmacognostical evaluation and establishment of quality parameters of medicinal plants of north-east India used by folklore healers for treatment of hypertension
CN101690738A (zh) 牛筋果及其提取物在制备抗肿瘤药物中的新用途
Huy et al. Inhibition of calculi forming oxalate by dietary Basella rubra organs: Litholytic activity
Thenmozhi et al. Evaluation Of Antimitotic Activity Of Solanum Torvum Using Allium Cepa Root Meristamatic Cells And Anticancer Activity Using MCF-7-Human Mammary Gland Breast Adenocarcinoma Cell Lines.
Sinvula Green synthesis of silver nanoparticles using Moringa oleifera extracts and their evaluation against antibiotic resistant strains of escherichia coli and staphylococcus aureus
Pal et al. Sunflower and Passiflora Seeds and Their Roles in Cancer with Special Reference to Secondary Metabolites Present Within Them
ES2906473B2 (es) Extracto etanólico de semillas de Solanum melongena, método para obtenerlo, composición farmacéutica que lo contiene y su uso como agente antitumoral
Lim Styphnolobium japonicum
Raja et al. Morinda citrifolia L.: Phyto-pharmacological perspective review
Lim Prunus persica var. persica
Pandhare et al. Neuroprotective potential of indian herbs in ischaemic stroke: a comprehensive review of pharmacological insights, therapeutic gaps, and future directions
Elhaw Physiological and biochemical studieson Galium sinaicum plant

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20141210

WD01 Invention patent application deemed withdrawn after publication